CD70 / TNFSF7 (Activated T- & B-Lymphocyte Marker) Antibody - Without BSA and Azide
Mouse Monoclonal Antibody [Clone TNFS7/1026 ]
|Application ||IHC-F, IF, FC, E, IP|
|Other Accession||970, 501497, 715224|
|Isotype||Mouse / IgG1, kappa|
|Other Names||CD70 antigen, CD27 ligand, CD27-L, Tumor necrosis factor ligand superfamily member 7, CD70, CD70, CD27L, CD27LG, TNFSF7|
|Storage||Store at 2 to 8°C.Antibody is stable for 24 months.|
|Precautions||CD70 / TNFSF7 (Activated T- & B-Lymphocyte Marker) Antibody - Without BSA and Azide is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||CD27L, CD27LG, TNFSF7|
|Function||Cytokine that binds to CD27. Plays a role in T-cell activation. Induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells.|
|Cellular Location||Membrane; Single-pass type II membrane protein|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
It recognizes a protein of 30kDa, identified as CD70. It is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T- and B-lymphocytes. It induces proliferation of co-stimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin synthesis.
Lens, S.M., et al. 1995. CD27-CD70 interaction: unravelling its implication in normal and neoplastic B cell growth. Leuk. Lymphoma 18: 51-59
If you have any additional inquiries please email technical services at firstname.lastname@example.org.